繁體版 簡體版
 
 
About SciVision  
Home > About Us > About SciVision
 
The leading company of Hyaluronic acid technology
SciVision Biotech Inc. was established by a professional team with master’s and doctoral degrees in the hinterland of Kaohsiung Harbor in 2001. SciVision Biotech Inc. manufactures Hyaluronic acid products by using own-developed Cross-linked Hyaluronic Acid Platform (CHAP), and breaks the bottleneck of modern technology, making the characteristics of Hyaluronic acid products be precisely controllable, and can be widely  
used in the production of cross-linked Hyaluronic acid products with different states and physical properties. The technology of Cross-linked Hyaluronic Acid Platform (CHAP) established the leading position of SciVision Biotech Inc. in the field of medical grade Hyaluronic acid products.
With the social and economic development, as well as the improving living standards, the population structures of both developed and developing countries are gradually moving towards an aging society. The pursuit of beauty and health, as well as the demand for medical care of degenerative diseases has increased day by day. The main products of our company are Hyaluronic acid dermal fillers (for medical and cosmetic surgical use), Hyaluronic acid anti-adhesion gels (for surgical use) and Hyaluronic acid viscosupplement (for treatment of knee osteoarthritis). The three Hyaluronic acid products are high-level medical devices that could cater to the commercial possibilities in the biotechnology and medicine markets.

The industry has certified our international quality management certification.
The safety and performance of our products has been qualified through the relevant in vivo, in vitro experiments and clinical trials. The experimental results had also been published in internationally renowned journals. In 2003 and 2008, SciVision Biotech Inc. passed the “Leading New Product Development Research” of the Ministry of Economic Affairs, and our products were awarded by “National Biotechnology and Medicine Quality Award” in 2008. In 2012, our products were also awarded by “the 2nd National Industry Innovation Award” of the Ministry of Economic Affairs, and the “9th National New Innovation Award” of the Institute for Biotechnology and Medicine Industry. At present, our products have been widely adopted in the markets, and are favored as well as allied by the international companies.
Our production management has been introducing ISO international quality management system and in compliance with the Medical Device Good Manufacturing Practice (GMP). At present, hyaluronic acid dermal fillers and hyaluronic acid viscosupplement have obtained CE certificates from European Union authorities, as well as domestic and international sale licenses. It has been sold in the global markets for years. The hyaluronic acid anti-adhesion gel has also obtained a sale license from Taiwanese Food and Drug Administration in 2017. Recently, it is sold in domestic medical centers and hospitals.
 
SciVision which is combined with “Science” and “Vision” means “Science creates better vision.”
As the whole concept of the logo, “SciVision”, our company will never stop to explore the cutting-edge research in the field of biotechnology, uphold the concept of continuous innovation, and develop new products. It not only retains originality, but also continuously keeps in touch with the modern technology. Today, our company has gradually increased the technology scale and is being devoted to the health and beauty fields, to create a better vision and reach the human’s aesthetic realm. In the future, our operating plan will still focus on Taiwan which is an important base of research and development, as well as manufacturing, and be being dedicated to expanding business into overseas markets.